tiprankstipranks

Stephen Rushworth Smith Insider Profile

4 Followers
Stephen Rushworth Smith, Director at Allergy Therapeutics, holds 776.51K shares in Allergy Therapeutics (Ticker: GB:AGY). Most recently, Stephen Rushworth Smith Bought 20,000p shares of Allergy Therapeutics on Apr 20, 2012 for an estimated value of ―.
tipranks
Stephen Rushworth Smith

Stephen Rushworth Smith
Allergy Therapeutics (AGY)
Director

Not Ranked
Stephen Rushworth Smith has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£24K
100.00%
A breakdown of Stephen Rushworth Smith's holdings

Insider Roles

Allergy Therapeutics
(AGY)
Director
Roles that Stephen Rushworth Smith holds in companies

Most Profitable Insider Trade

Stock:
Allergy Therapeutics
(AGY)
Rating:Informative Buy
Date:Apr 20, 2012 - Apr 20, 2013
Return:+11.80%
The most profitable trade made by Stephen Rushworth Smith

Stephen Rushworth Smith's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Allergy Therapeutics
Apr 20, 2012
Director
Informative Buy
£24.46K
Success Rate for
AGY
1 out of 1 profitable transactions on
AGY
100%
Average Return for
AGY
Average return per transaction on
AGY
+11.80%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Apr 20, 2012
Informative Buy
£0.00
-
£0.00
+11.80%
Jun 12, 2009
Uninformative Sell
£37.50K
-
£5.00
List of latest transactions for each holding click on a transaction to see Stephen Rushworth Smith's performance on stock

Stephen Rushworth Smith insider profile FAQ

What is the percentage of profitable transactions made by Stephen Rushworth Smith?
The percentage of profitable transactions made by Stephen Rushworth Smith is ―.
    What is the average return per transaction made by Stephen Rushworth Smith?
    The average return per transaction made by Stephen Rushworth Smith is ―.
      What stocks does Stephen Rushworth Smith hold?
      Stephen Rushworth Smith holds: GB:AGY stocks.
        What was Stephen Rushworth Smith’s latest transaction?
        Stephen Rushworth Smith latest transaction was an Informative Buy of ―.
          What was Stephen Rushworth Smith's most profitable transaction?
          Stephen Rushworth Smith’s most profitable transaction was an Informative Buy of GB:AGY stock on April 20, 2012. The return on the trade was 11.80%.
            What is Stephen Rushworth Smith's role in Allergy Therapeutics?
            Stephen Rushworth Smith's role in Allergy Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.